CSE:SONA OTCQB:SNANF

Sona Nanotech Inc

Market:

CSE

Price

0.56 CAD

Day Change

-

Market Cap:

$63.02 m

52 weeks high

0.56

52 weeks low

0.24

Filter by article type

Viewing results 1-25 of 32

Video

Sona Nanotech achieves first patient dosing in clinical trial of Targeted Hyperthermia Therapy

3 days, 1 hour ago

News

Sona Nanotech doses first patient in cancer therapy feasibility study

3 days, 4 hours ago

Sona Nanotech is developing targeted cancer therapies and rapid diagnostic tests using gold nanoparticles

3 days, 4 hours ago

News

Sona Nanotech gets ethics committee nod to launch early-stage cancer therapy trial

1 week, 6 days ago

News

Sona Nanotech signs Chile trial partner for targeted hyperthermia therapy trial - ICYMI

2 weeks, 5 days ago

Video

Sona Nanotech initiates clinical trial for Hyperthermia Therapy in advanced Melanoma patients

3 weeks, 3 days ago

News

Sona Nanotech engages clinic for first-in-human trial of THT cancer therapy

3 weeks, 3 days ago

Sona Nanotech on a mission to make cancer treatment more effective with fewer side effects

on 06/02/2025

News

Sona Nanotech hits milestone in human trial readiness - ICYMI

on 05/30/2025

Video

Sona Nanotech achieves key safety milestone for gold nanorod therapy platform

on 05/27/2025

News

Sona Nanotech advances cancer therapy program with positive preclinical study results

on 05/27/2025

News

Sona Nanotech advances toward first-in-human gold nanorod trial - ICYMI

on 05/24/2025

Video

Sona Nanotech clears Endotoxin testing, preps for first-in-human Gold Nanorod trial

on 05/21/2025

News

Sona Nanotech completes endotoxin testing ahead of human study

on 05/15/2025

News

Sona Nanotech teams with BioVaxys on cancer tech – ICYMI

on 05/09/2025

Video

Sona Nanotech and BioVaxys Partner to develop next-generation cancer therapies

on 05/08/2025

News

Sona Nanotech and BioVaxys partner to develop novel cancer therapy

on 05/07/2025

News

Sona Nanotech grants stock options as THT cancer treatment nears clinical trials

on 05/01/2025

News

Sona Nanotech chief medical officer talks latest targeted hyperthermia therapy findings - ICYMI

on 03/29/2025

Healthcare investment strategies reshaped by inflation, interest rates and M&A in 2025

on 03/21/2025

Video

Sona Nanotech CMO discusses THT's potential to enhance immunotherapy efficacy

on 03/21/2025

News

Sona Nanotech confirms THT's potential to enhance immunotherapy efficacy in preclinical study

on 03/19/2025

News

Sona Nanotech to present gold nanorod cancer therapy research at Canadian Melanoma Conference

on 02/12/2025

Video

Sona Nanotech advances gold nanoparticle hyperthermia technology for cancer treatment

on 02/07/2025

News

Sona Nanotech's gold nanorod study hits peer-reviewed journal - ICYMI

on 02/01/2025

	
		OSZAR »